MTW NHS Trust West Kent CCG

Drug Status Key

  • Preferred
  • Second Line
  • Third Line
  • Specialist Initiation
  • Hospital Only
  • Not Approved for Formulary

Emergency contraception

Drug Safety Update

February 2021: Ulipristal acetate 5mg (Esmya): further restrictions due to risk of serious liver injury

 March 2020: Esyma (ulipristal acetate) suspension of the licence due to risk of serious liver injury 

 August 2018: Esmya (ulipristal acetate) and risk of serious liver injury: new restrictions to use and requirements for liver function monitoring before, during, and after treatment

 March 2018: Esmya (ulipristal acetate) for uterine fibroids: do not initiate or re-start treatment; monitor liver function in current and recent users

 September 2016: Levonorgestrel-containing emergency hormonal contraception: advice on interactions with hepatic enzyme inducers and contraceptive efficacy

 August 2014: Levonorgestrel and ulipristal remain suitable emergency contraceptives for all women

See above Drug Safety Update link: the licence for ulipristal (Esyma) has been suspended, current treatment should be stopped and no new patients commenced on this treatment

Ulipristal (EllaOne) is still licensed for emergency contraception

Pack Price
1 tablet £14.05

licence has been suspended due to safety concerns please see Drug Safety Update link above. Current treatment should be stopped and no patients started on this treatment

Pack Price
28 tablet (2 x 14 tablets) £114.13